DIA
PTVE

Dean Investment Associates’s Pactiv Evergreen Inc. Common stock PTVE Stock Holding History

Dean Investment Associates’s Portfolio PTVE Stock Details PTVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-149,861
Closed -$2.26M – 241
2021
Q2 		$2.26M Sell
149,861
-6,997
-4% -$105K 0.42% 95
2021
Q1 		$2.15M Buy
156,858
+36,507
+30% +$566K 0.41% 102
2020
Q4 		$2.18M Buy
+120,351
New +$1.86M 0.45% 85

Other funds holding PTVE

American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
TC
Towle & Co Denver, Colorado $257M AUM 73.13% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Dean Investment Associates's PTVE Position: Q3 2021 in Review

Dean Investment Associates sold out of Pactiv Evergreen Inc. Common stock (PTVE) in Q3 2021, closing a stake of 149,861 shares — an estimated $2.26M sold.

Dean Investment Associates first reported a position in PTVE in Q4 2020 and held it in 3 quarters. The position peaked at $2.26M in Q2 2021. 68 funds tracked by Wall St. Rank hold PTVE as of Q3 2021.

  • Dean Investment Associates reported no remaining Pactiv Evergreen Inc. Common stock position as of Q3 2021 after selling out during the quarter.
  • Dean Investment Associates sold 149,861 Pactiv Evergreen Inc. Common stock shares in Q3 2021, an estimated $2.26M.
  • Dean Investment Associates first reported a position in Pactiv Evergreen Inc. Common stock in Q4 2020 and held it in 3 quarters.
  • Dean Investment Associates's Pactiv Evergreen Inc. Common stock position peaked at $2.26M in Q2 2021.
  • 68 funds tracked by Wall St. Rank held Pactiv Evergreen Inc. Common stock as of Q3 2021.

Based on Dean Investment Associates's 13F filing for Q3 2021, filed 12 Nov 2021.